These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1646410)

  • 1. Prevalence of antibodies to hepatitis C virus in sera from patients with systemic necrotizing vasculitis.
    Theilmann L; Gmelin K; Kallinowski B; Kommerell B; Koderisch J; Andrassy K
    Nephron; 1991; 57(4):482. PubMed ID: 1646410
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to hepatitis C virus in people from Yucatan, Mexico.
    Góngora-Biachi RA; González-Martínez P; Puerto FI; Yamaguchi K; Nishimura Y; Takatsuki K
    Rev Invest Clin; 1992; 44(2):284. PubMed ID: 1332170
    [No Abstract]   [Full Text] [Related]  

  • 3. Serological prevalence of hepatitis C virus in a population of subjects with human immunodeficiency virus infection.
    Lafeuillade A; Zandotti C; Tamalet C; Quilichini R; Gastaut JA
    Postgrad Med J; 1991 Aug; 67(790):777. PubMed ID: 1661417
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis-C virus (HCV) in peritoneal dialysis.
    Krautzig S; Tillmann H; Wrenger E; Manns M; Koch KM; Brunkhorst R
    Clin Nephrol; 1994 Feb; 41(2):120. PubMed ID: 7516274
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of antibodies to hepatitis C virus among Turkish patients with chronic liver disease.
    Ozyilkan E; Tatar G; Köseoglu T; Telatar H
    J Intern Med; 1993 Mar; 233(3):303-4. PubMed ID: 7680706
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of anti-HCV antibodies in Cameroon.
    Mencarini P; De Luca A; Antinori A; Maiuro G; Spedini G; Bailly C; Tamburrini E
    Trans R Soc Trop Med Hyg; 1991; 85(5):654-5. PubMed ID: 1664151
    [No Abstract]   [Full Text] [Related]  

  • 7. [The prevalence of antibodies directed against hepatitis C virus in hepatocellular carcinoma: relation to hepatitis B virus, Pugh's score, Okuda's staging and survival].
    Giovannini M; Seitz JF; Pingannaud MP; Sauvan R; Rossi I; Pasquier J; Gauthier A
    Ann Gastroenterol Hepatol (Paris); 1991; 27(1):36. PubMed ID: 1851405
    [No Abstract]   [Full Text] [Related]  

  • 8. [Seroprevalence of hepatitis C virus antibodies in obstetric patients at the Nuevo Hospital Civil de Guadalajara].
    Gamboa R; Gaxiola Castro R; Guana Flores R; Silva Maciel CA; Becerra Leyva G
    Ginecol Obstet Mex; 1994 Dec; 62():399-402. PubMed ID: 7530675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria. Relationship with other blood borne viruses and liver disease.
    Leslie DE; Rann S; Nicholson S; Fairley CK; Gust ID
    Med J Aust; 1992 Jun; 156(11):789-92. PubMed ID: 1321326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of antibodies to hepatitis C virus in hemodialysis patients.
    Kallinowski B; Theilmann L; Gmelin K; Andrassy K; Deppermann D; Weinel B; Kommerell B
    Nephron; 1991; 59(2):236-8. PubMed ID: 1659672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus antibody and hepatitis C viremia in pediatric dialysis patients in Taiwan.
    Lin CY; Lin JY; Chen WP
    Nephron; 1993; 65(4):654. PubMed ID: 7508095
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serological study on hepatitis C (HCV) in 4371 blood donors].
    Arnone M; Pinducciu G; Usai M; Pitzus F; Pintus L
    Ann Ig; 1990; 2(5):353-8. PubMed ID: 1715726
    [No Abstract]   [Full Text] [Related]  

  • 13. High incidence of hepatitis C virus antibodies in hemodialysis patients.
    Machida J; Yamaguchi K; Ueda S; Yoshida M; Kusumoto Y; Nishimura Y; Futami G; Ishii T; Watanabe T; Takatsuki K
    Nephron; 1992; 60(1):117-8. PubMed ID: 1310800
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C virus testing of sera in Africa.
    Aceti A; Taliani G
    Trans R Soc Trop Med Hyg; 1992; 86(6):676. PubMed ID: 1337635
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of hepatitis C antibodies in patient groups in Egypt.
    Hassan NF
    Trans R Soc Trop Med Hyg; 1993; 87(6):638. PubMed ID: 7507607
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of antibodies to hepatitis C virus (anti-HCV) in different populations in Taiwan.
    Wu JS; Lu CF; Liu WT; Lin SY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Feb; 24(1):55-60. PubMed ID: 1657545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further insights into hepatitis C.
    Colombo M
    Ital J Gastroenterol; 1991 Dec; 23(9):574-5. PubMed ID: 1662092
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C virus in patients with acute and chronic liver disease.
    Mehta SK; Singh V; Bhasin DK; Kumar YR; Kochhar R
    Indian J Gastroenterol; 1992 Jul; 11(3):146. PubMed ID: 1380490
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis C virus antibody in acute and chronic liver diseases in India.
    Gupta H; Irshad M; Joshi YK; Acharya SK; Tandon BN
    Scand J Infect Dis; 1990; 22(5):627. PubMed ID: 2175450
    [No Abstract]   [Full Text] [Related]  

  • 20. Inconclusive hepatitis C virus antibody results in African sera.
    Hyams KC; Okoth FA; Tukei PM; Vallari DS; Morrill JC; Long G; Bansal J; Constantine N
    J Infect Dis; 1993 Jan; 167(1):254-5. PubMed ID: 7678108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.